Financial Advisor Jim Martin and Team Launch Nordwand Capital, a $5 billion Multi-Family Office and Investment Firm in Radnor, PA
Clients Consist of a Select Number of Families With Over $100 Million ST. PETERSBURG, Fla.–(BUSINESS…
Social Media
Nautilus Biotechnology Launches “First Access Challenge”
Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data…
OSARO and SVT Robotics Partner to Accelerate Advanced Packaging Robot Integration and Deployment in Fulfillment Warehouses
OSARO’s customers benefit from streamlined access to SVT’s SOFTBOT® Platform, which shortens automation deployment and…
Freeze.com is the First Data Privacy Solution that Stops Data Brokers From Selling Consumer Data at Scale
With growing consumer demand for stronger data privacy and identity protection, Freeze acts on behalf…
Avicanna Reports Q3 2022 Financial Statement
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) — NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES…
H2O.ai Unleashes H2O World in Sydney with Commonwealth Bank of Australia in the Largest Gathering of AI Grandmasters in the World
Event marks the biggest gathering of world’s best data scientists in Australian history as professionals…
Iveda Solutions® Selects Dotted Line Communications and Automations Solutions Agency as North American PR and Social Media Agencies
MESA, Ariz.–(BUSINESS WIRE)–Iveda Solutions® (NASDAQ:IVDA), the global solution for cloud-based AI technology, today announced Dotted…
Systematic+ Unveils Findings from Annual State of Business Technology Report, Showcasing the Evolution of IT Teams
The annual report from the leading enterprise automation platform highlights changing sentiments amongst business technology…
Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling Efficient Multitool/Multiplex Gene Engineering combining TALEN® and TALE Base Editors (TALE-BE)
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
GreenLight Biosciences lab GreenLight Biosciences lab Working toward clinical trial initiation for COVID vaccine candidate…
WNS Recognized as a ‘Leader’ in AI and Analytics & Social Media for CX Services by ISG
NEW YORK & LONDON & MUMBAI, India–(BUSINESS WIRE)–$WNS #AI–WNS (Holdings) Limited (NYSE: WNS), a leading…
Inspiring with STEM: Intelsat Begins Application Process for STEM Program in Africa
MCLEAN, Va.–(BUSINESS WIRE)–Intelsat, operator of the world’s largest integrated satellite and terrestrial networks and leading…
GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
Credit Suisse annual conference GreenLight CEO Andrey Zarur will present to the Credit Suisse 31st…
Sandoz announces further investment in key manufacturing facility in Austria, to support increased global demand for essential antibiotics
EUR 50m planned investment to support increased manufacturing capacity for finished dosage form penicillins, the…
United States Digital Advertising Market Analysis Report 2022-2026: Artificial Intelligence, Programmatic Ads, & Involvement of Big Data Gaining Traction – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “The US Digital Advertising Market (By Format, Devices and Industry): Insights & Forecast…
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2022
ASH 2022 sponsored programs – UCART123 abstract selected for oral presentation & preclinical data on…
Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., Nov. 03,…
Cellectis to Showcase Clinical Data from AMELI-01 and Preclinical Data from UCARTCS1 at ASH 2022
• AMELI-01 (evaluating UCART123) abstract, selected for oral presentation, highlights that adding alemtuzumab was associated…
AI Proteins Secures $18.2 Million Seed Round to Pioneer High-Throughput Platform for Advanced Miniprotein Therapeutics
Company to focus on the rapid development of miniproteins tailor-made for therapeutics, driving down costs…
Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022
Company to host KOL conference call and webcast on Monday, December 12 at 5:00 p.m….